Upper Urinary Tract Urothelial Carcinoma
Oncology·MeSH: Carcinoma, Transitional Cell
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ugn-104 | UroGen Pharma Ltd. (URGN) |
Frequently asked questions
How many drugs are in development for Upper Urinary Tract Urothelial Carcinoma?
BioSniper tracks 1 drug in development for Upper Urinary Tract Urothelial Carcinoma across 1 company.
How many clinical trials target Upper Urinary Tract Urothelial Carcinoma?
There are 1 clinical trial targeting Upper Urinary Tract Urothelial Carcinoma tracked by BioSniper.
What is the prevalence of Upper Urinary Tract Urothelial Carcinoma?
The estimated prevalence of Upper Urinary Tract Urothelial Carcinoma is approximately 5.0 per 100,000 population.
Deep-dive into Upper Urinary Tract Urothelial Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis